Loading...
Lexaria Bioscience's Breakthrough with DehydraTECH to Revolutionize Drug Delivery
IN
InvestingNurse
Not Invested
Community Contributor
Published
26 Jan 26
Views
200
26 Jan
US$0.58
InvestingNurse's Fair Value
US$5.55
89.5% undervalued intrinsic discount1Y
-39.4%7D
-3.5%1Y
-39.4%7D
-3.5%You can edit this narrative until Jan 27 2:20 PM. Then, changes will post as Updates.
Author's Valuation
US$5.5589.5% undervalued intrinsic discount
InvestingNurse's Fair Value